Loading…
← CockpitCompetitor Analysis › TRUP Trupanion, Inc.Open in the cockpit ↗

Trupanion, Inc.TRUPCompetitor analysis, valuation and peers

United States · USD·Financials›Multi-Line Insurance

Sells monthly pet medical insurance in the US and Canada, paying veterinary invoices directly at time of treatment.

Momentum leader 96
Mkt cap
$1.59B
US dollars, full cap
Free float
70%
of shares outstanding
$/day
$15.4M
20-day average traded
P/B
3.98×
price to book
ROE
6.9%
delivered
Implied ROE
36.4%
what the price asks
Next earnings
91 days
17 Feb 2027
Close · USD$36.68
1D+0.4%
1W+6.8%
1M+27.5%
3M+19.6%
6M+67.6%
YTD-1.9%
1Y+0.9%
ATR %4.2%
Beta-0.03
52w lowhigh5.6% off high

What Trupanion does

Sells monthly pet medical insurance in the US and Canada, paying veterinary invoices directly at time of treatment.

Collects monthly premiums and keeps what is not paid out in claims, so results depend on pricing ahead of veterinary cost inflation and on policies staying in force as pets age. It carries the insurance risk itself and wins customers largely through vet clinics and referrals.

Products and services

  • Pet insurance (dogs & cats)
  • Direct veterinary software integration

Customers

  • Pet owners
  • Veterinary hospitals (direct-pay partners)

Where it sits in the supply chain

  • Financials
  • Insurance
  • Pet health insurance

What could go right

  • Rising pet ownership and vet spend
  • Expanding vet hospital direct-pay network

What could go wrong

  • Veterinary cost inflation squeezing margins
  • Competitive discounting from larger insurers

Moat: narrow (distribution, brand, switching costs). Direct-pay veterinary software integration is a differentiated, hard-to-replicate claims experience.

Headquarters: Seattle, Washington, United States · Founded: 2000 · Employees: 1,121

Named competitors

Trupanion at a glance

Size Trupanion (TRUP) is a United States Financials company (Multi-Line Insurance) with a market value of $1.59B, the 1934th largest of 3,085 United States companies the cockpit tracks. Shares closed at $36.68 on 18 Nov 2026.

Performance Over six months the shares gained 67.6%, against -1.6% for the median peer and -2.2% for the United States market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue grew 11.4% over the last twelve months (peer median +10.2%); the operating margin is 1.9% (peer median 9.5%).

Valuation It trades at 3.98× book value against a peer median of 1.04× (2nd most expensive of 21).

Price implies The share price implies a return on equity of about 36.4%; Trupanion delivers 6.9%, so the price asks more than the business earns today.

Short interest Short interest is 9.1% of the free float (30 Oct 2026).

Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012515021 May 202621 Aug 202618 Nov 2026TRUP 168Peer median 97
Six months, rebased to 100: Trupanion against the median of its 20 peers (local-currency closes).

Trupanion financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.56B$1.44B$1.29B$1.11B$905M
Revenue growth—+12%+16%+22%—
Net income$26.6M$19.4M-$9.63M-$44.7M-$44.7M
Free cash flow$86.7M$75.4M$38.6M$358,000-$25.1M
Capital expenditure$8.84M$14.1M$9.72M$18.3M$17.1M
Total debt$104M$112M$129M$129M$69.5M

Quarterly statements and history in the cockpit →

Trupanion competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%+60%0%+20%LDA003690WUW6060031210BOWNHFPLGO2851GODIGITCSNVAHNNIACLSKWDGNWFGLMNDDGICATRUP6-month return →1-month return →
Up and to the right = strong over both horizons. Trupanion is the large dot.

Fundamentals: return on equity against price-to-book

0%10%20%20×40×LDA003690WUW6060031210BOWNHFPLGO2851GODIGITCSNVAHNNIACLSKWDGNWFGLMNDSFCRELIGAREDGICATRUPReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Trupanion is the large dot.

Capital: ROE delivered against the ROE the price implies

-25%0%25%50%75%0%50%LDA003690WUW60602851GODIGITCSNVAHNFGLMNDTRUPROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Trupanion is the large dot.

Trupanion competitors and peer comparison

Head to head with its named competitors (TRUP vs MET vs CHWY)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Trupanion TRUP$1.59B+68%+11%7%3.98×36.4%
MetLife MET$62.7B+21%+15%20%2.83×19.9%
Chewy CHWY$8.32B+3%+6%72%22.43×198.5%

How Trupanion compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Trupanion against its 20 peers (data as of 18 Nov 2026)
MeasureTRUPPeer medianRank in peer set
1-month return+27.5%+1.4%highest of 21
6-month return+67.6%-1.6%highest of 21
Return on equity6.9%8.1%10th lowest of 21
Price / book3.98×1.04×2nd most expensive of 21
Trailing P/E60.2×14.4×4th most expensive of 19
ROE the price implies36.4%8.1%2nd most demanding of 21
ROE delivered6.9%8.2%9th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Trupanion TRUPUnited States$1.59B+68%+11%7%3.98×36.4%6.9%
Linea Directa Aseguradora LDA.MCSpain$1.50B+6%+10%23%3.17×12.3%23.3%
Korean Reinsurance 003690.KSSouth Korea$1.71B+5%+10%14%0.75×4.9%13.7%
Wuestenrot & Wuerttembergische WUW.DEGermany$1.39B-8%+4%3%0.25×3.8%2.7%
Zhongan Online P&C Insurance 6060.HKHong Kong$1.87B-19%+16%8%0.47×7.6%8.2%
Seoul Guarantee Insurance 031210.KSSouth Korea$2.11B-13%+19%6%0.57×4.5%5.6%
Bowhead Specialty BOWUnited States$1.13B+20%+24%14%2.50×11.9%13.6%
NIB NHF.AXAustralia$2.24B0%+5%17%2.93×13.3%16.6%
Pelagos Insurance Capital PLGOUnited States$2.28B+19%+4%15%1.02×6.6%14.6%
Central Reinsurance 2851.TWTaiwan$1.06B+38%+3%35%1.31×4.9%35.2%
Go Digit General Insurance GODIGIT.NSIndia$2.38B-23%+12%8%2.73×22.4%8.1%
Chesnara CSN.LUnited Kingdom$1.05B+6%+192%0%2.12×15.9%0.3%
Vaudoise Assurances VAHN.SWSwitzerland$2.62B-3%+14%6%0.79×1.9%5.9%
New India Assurance NIACL.NSIndia$2.64B-9%+9%-1%0.59×13.5%-1.3%
Skyward Specialty Insurance SKWDUnited States$2.82B+34%+35%17%2.21×11.0%17.1%
Genworth Financial GNWUnited States$2.88B-15%-3%0%0.34×5.2%0.4%
F&G Annuities & Life FGUnited States$2.92B-20%-1%23%0.67×8.6%22.6%
Lemonade LMNDUnited States$3.07B-31%+89%-29%6.49×80.7%-29.3%
Sagicor Financial SFC.TOCanada$809M+1%-11%1%0.82×4.9%1.5%
Religare Enterprises RELIGARE.NSIndia$804M-3%+18%3%2.53×22.8%n/a
Donegal DGICAUnited States$758M+9%-3%11%1.05×6.8%10.7%

Questions

Who are Trupanion's main competitors?
Named competitors: MetLife Pet Insurance (MET), Nationwide Pet Insurance (private or unlisted), Embrace Pet Insurance (private or unlisted), Chewy (pet insurance partner) (CHWY). The cockpit's measured peer set (industry) also includes Linea Directa Aseguradora (LDA.MC), Korean Reinsurance (003690.KS), Wuestenrot & Wuerttembergische (WUW.DE), Zhongan Online P&C Insurance (6060.HK), Seoul Guarantee Insurance (031210.KS), Bowhead Specialty (BOW).
Is Trupanion expensive compared with its peers?
On price / book it trades at 3.98× against a peer median of 1.04×, 2nd most expensive of 21 in its peer set. The share price implies a return on equity of about 36.4%; Trupanion delivers 6.9%, so the price asks more than the business earns today.
How has Trupanion stock performed?
Over six months to 18 Nov 2026 the shares returned +67.6% against -1.6% for the median peer; over one year +0.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.